Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum
- PMID: 32913016
- PMCID: PMC7682829
- DOI: 10.1212/WNL.0000000000010727
Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum
Abstract
Objective: To characterize the cortical macrostructure and microstructure of behavioral and cognitive changes along the amyotrophic lateral sclerosis (ALS)-frontotemporal dementia (FTD) continuum.
Methods: We prospectively recruited 88 participants with a 3T MRI structural and diffusion-weighted imaging sequences: 31 with ALS, 20 with the behavioral variant of FTD (bvFTD), and 37 cognitively normal controls. Participants with ALS underwent a comprehensive cognitive and behavioral assessment and were dichotomized into ALS without cognitive or behavioral impairment (ALSno-cbi; n = 12) and ALS with cognitive or behavioral impairment (ALScbi; n = 19). We computed cortical thickness and cortical mean diffusivity using a surface-based approach and explored the cortical correlates of cognitive impairment with the Edinburgh Cognitive and Behavioral ALS Screen.
Results: The ALSno-cbi and ALScbi groups showed different patterns of reduced cortical thickness and increased cortical mean diffusivity. In the ALSno-cbi group, cortical thinning was restricted mainly to the dorsal motor cortex. In contrast, in the ALScbi group, cortical thinning was observed primarily on frontoinsular and temporal regions bilaterally. There were progressive cortical mean diffusivity changes along the ALSno-cbi, ALScbi, and bvFTD clinical continuum. Participants with ALS with either cognitive or behavioral impairment showed increased cortical mean diffusivity in the prefrontal cortex in the absence of cortical thickness.
Conclusions: Cortical mean diffusivity might be a useful biomarker for the study of extramotor cortical neurodegeneration in the ALS-FTD clinical spectrum.
Classification of evidence: This study provides Class III evidence that the cortical microstructure correlates with cognitive impairment in the ALS-FTD continuum.
© 2020 American Academy of Neurology.
Figures
Similar articles
-
Phenotypic variability in ALS-FTD and effect on survival.Neurology. 2020 May 12;94(19):e2005-e2013. doi: 10.1212/WNL.0000000000009398. Epub 2020 Apr 10. Neurology. 2020. PMID: 32277059
-
Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis.Neurobiol Aging. 2014 Jan;35(1):240-6. doi: 10.1016/j.neurobiolaging.2013.07.020. Epub 2013 Aug 28. Neurobiol Aging. 2014. PMID: 23992619
-
Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype.Neuroimage Clin. 2016 Oct 22;12:1035-1043. doi: 10.1016/j.nicl.2016.10.014. eCollection 2016. Neuroimage Clin. 2016. PMID: 27995069 Free PMC article. Clinical Trial.
-
The anatomy of cognitive impairment in amyotrophic lateral sclerosis: more than frontal lobe dysfunction.Cortex. 2012 Feb;48(2):166-82. doi: 10.1016/j.cortex.2011.02.004. Epub 2011 Feb 12. Cortex. 2012. PMID: 21396632 Review.
-
Cognitive and behavioural impairment in amyotrophic lateral sclerosis: A landmark of the disease? A mini review of longitudinal studies.Neurosci Lett. 2021 May 29;754:135898. doi: 10.1016/j.neulet.2021.135898. Epub 2021 Apr 15. Neurosci Lett. 2021. PMID: 33862143 Review.
Cited by
-
Evidence based on Mendelian randomization and colocalization analysis strengthens causal relationships between structural changes in specific brain regions and risk of amyotrophic lateral sclerosis.Front Neurosci. 2024 Mar 5;18:1333782. doi: 10.3389/fnins.2024.1333782. eCollection 2024. Front Neurosci. 2024. PMID: 38505770 Free PMC article.
-
Association of cortical and subcortical microstructure with disease severity: impact on cognitive decline and language impairments in frontotemporal lobar degeneration.Alzheimers Res Ther. 2023 Mar 21;15(1):58. doi: 10.1186/s13195-023-01208-7. Alzheimers Res Ther. 2023. PMID: 36941645 Free PMC article.
-
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies.Front Neurol. 2022 Jan 18;12:750543. doi: 10.3389/fneur.2021.750543. eCollection 2021. Front Neurol. 2022. PMID: 35115992 Free PMC article. Review.
-
Low Fluctuation of Symptoms May Delay Diagnosis of Myasthenia Gravis: A Case Series.Neurol Ther. 2022 Mar;11(1):481-487. doi: 10.1007/s40120-021-00312-w. Epub 2021 Dec 18. Neurol Ther. 2022. PMID: 34921343 Free PMC article.
-
Amyotrophic Lateral Sclerosis-Frontotemporal Dementia: Shared and Divergent Neural Correlates Across the Clinical Spectrum.Neurology. 2022 Jan 24;98(4):e402-e415. doi: 10.1212/WNL.0000000000013123. Neurology. 2022. PMID: 34853179 Free PMC article.
References
-
- Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017;377:162–172. - PubMed
-
- Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol 2012;124:339–352. - PubMed
-
- Elamin M, Phukan J, Bede P, et al. . Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011;76:1263–1269. - PubMed
-
- Elamin M, Bede P, Byrne S, et al. . Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 2013;80:1590–1597. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous